Curis (CRIS) Stock Price, Quote, News & History | Benzinga

Curis Inc (CRIS) Stock Price, Quote, News & History

CRISNASDAQ

Trade with Public

Trade with Public

$1.80

-0.07-3.74%

At close: Aug 14, 5:00 PM EST

$1.87

0.07013.89%

After Hours: Aug 14, 4:48 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$1.83

Close

$1.80

Volume / Avg.

470.55K / 241.12K

Day Range

$1.74 - $2.08

52 Wk Range

1.54 - 39.00

Market Cap

$3.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

25

Short Interest

5.42%

Days to Cover

1.79

Recent Curis Inc News

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.

Vandana Singh

Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.

Vandana Singh

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.

Avi Kapoor

Why Did Curis (CRIS) Stock Soar After Hours?

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stock split will take effect on Thursday.

Mohd Haider

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.95M

Investing Cash Flow (TTM)

2.50M

Financing Cash Flow (TTM)

21.17M

Free Cash Flow (TTM)

-28.95M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-5.28M

Analyst Trends and Forecast

1

Mar

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$384.64K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.21

PB Ratio (TTM)

0.31

Earnings Yield % (TTM)

-625.34%

Earnings Yield % (FWD)

-1154.18%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.08

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.00M

Debt to Equity

0.11

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.83

Close

$1.80

Volume / Avg.

470.55K / 241.12K

Day Range

$1.74 - $2.08

52 Wk Range

1.54 - 39.00

Market Cap

$3.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

25

Short Interest

5.42%

Days to Cover

1.79

About

Sector

Health Care

Industry

Biotechnology

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hem...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Curis (CRIS) stock?

A

You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Curis (CRIS) competitors?

A

Other companies in Curis’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Curis (CRIS) stock?

A

Curis has a consensus price target of $21.00.

Q

What is the current price for Curis (CRIS)?

A

The stock price for Curis (NASDAQ: CRIS) is $1.8701 last updated August 14, 2026 at 4:48 PM EDT.

Q

Does Curis (CRIS) pay a dividend?

A

There are no upcoming dividends for Curis.

Q

When is Curis (NASDAQ:CRIS) reporting earnings?

A

Curis does not have any upcoming earnings scheduled.

Q

Is Curis (CRIS) going to split?

A

There is no upcoming split for Curis.

Q

What sector and industry does Curis (CRIS) operate in?

A

Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.